CSMYF Earnings Reports, EPS & Revenue History
Quarterly EPS and revenue vs. estimates for COSMOS Pharmaceutical Corporation. Review beat/miss history, upcoming consensus figures, and earnings call transcripts when available.
EPS and Earnings Announcement
Latest Quarterly EPS
Next Earnings Announcement
Unlock for free
Already registered? Sign in
EPS vs. Estimates
Green band = beat vs estimate · Red band = miss · Lines show actual and consensus EPS.
EPS & Revenue vs. Estimates
Upgrade| Date | EPS Actual | EPS Est. | EPS Diff. |
|---|---|---|---|
Jul 13, 2026 | 0.74 | 0.74 | -0.00 |
Apr 13, 2026 | 0.66 | 0.65 | +0.01 |
Jan 13, 2026 | 0.52 | 0.54 | -0.02 |
Oct 14, 2025 | — | — | — |
Jul 9, 2025 | — | — | — |
Apr 14, 2025 | — | — | — |
Jan 10, 2025 | — | — | — |
Oct 11, 2024 | — | — | — |
Jul 12, 2024 | — | — | — |
Apr 12, 2024 | — | — | — |
Feb 7, 2024 | — | — | — |
Aug 31, 2023 | — | — | — |
May 31, 2023 | — | — | — |
Feb 28, 2023 | — | — | — |
Jan 12, 2023 | — | — | — |
Oct 10, 2022 | — | — | — |
Jul 10, 2022 | — | — | — |
Apr 10, 2022 | — | — | — |
Jan 10, 2022 | — | — | — |
Oct 10, 2021 | — | — | — |
Jul 11, 2021 | — | — | — |
Apr 11, 2021 | — | — | — |
Jan 11, 2021 | — | — | — |
Oct 11, 2020 | — | — | — |
Jul 9, 2020 | — | — | — |
Apr 12, 2020 | — | — | — |
Jan 9, 2020 | — | — | — |
Oct 10, 2019 | — | — | — |
Jul 11, 2019 | — | — | — |
Apr 7, 2019 | — | — | — |
Jan 10, 2019 | — | — | — |
Oct 11, 2018 | — | — | — |
Jul 11, 2018 | — | — | — |
Apr 12, 2018 | — | — | — |
Jan 10, 2018 | — | — | — |
Oct 11, 2017 | — | — | — |
Jul 9, 2017 | — | — | — |
Apr 11, 2017 | — | — | — |
Jan 10, 2017 | — | — | — |
Oct 8, 2015 | — | — | — |
Earnings Call Transcripts
UpgradeEarnings Call Transcripts Require Subscription
Access to earnings call transcripts and AI-powered summaries is available for Pro, Premium, and Enterprise subscribers.
View Pricing PlansRevenue Breakdown
Want to understand CSMYF's revenue sources? Explore detailed revenue breakdowns by product line and geographic region to see what's driving the company's top line.
View Revenue Breakdown